SEC Filing Details

Document Details

Form
Filing Date
Feb 23, 2018
Document Date
Dec 31, 2017
Form Description
Annual report which provides a comprehensive overview of the company for the past year
Filing Group
Annual Filings
Company
Innoviva, Inc.
Issuer
THERAVANCE INC

Copyright Nasdaq. Minimum 15 minutes delayed.

Contact

Innoviva Investor Relations & Media
650.238.9640

For business development inquiries,
please contact bd@inva.com.